These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
303 related articles for article (PubMed ID: 29490625)
1. Impact of timing of adjuvant chemotherapy on survival in stage III colon cancer: a population-based study. Gao P; Huang XZ; Song YX; Sun JX; Chen XW; Sun Y; Jiang YM; Wang ZN BMC Cancer; 2018 Mar; 18(1):234. PubMed ID: 29490625 [TBL] [Abstract][Full Text] [Related]
2. Timing of adjuvant chemotherapy and its relation to survival among patients with stage III colon cancer. Bos AC; van Erning FN; van Gestel YR; Creemers GJ; Punt CJ; van Oijen MG; Lemmens VE Eur J Cancer; 2015 Nov; 51(17):2553-61. PubMed ID: 26360411 [TBL] [Abstract][Full Text] [Related]
3. Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer. Hershman D; Hall MJ; Wang X; Jacobson JS; McBride R; Grann VR; Neugut AI Cancer; 2006 Dec; 107(11):2581-8. PubMed ID: 17078055 [TBL] [Abstract][Full Text] [Related]
4. Comparative effectiveness of oxaliplatin vs non-oxaliplatin-containing adjuvant chemotherapy for stage III colon cancer. Sanoff HK; Carpenter WR; Martin CF; Sargent DJ; Meyerhardt JA; Stürmer T; Fine JP; Weeks J; Niland J; Kahn KL; Schymura MJ; Schrag D J Natl Cancer Inst; 2012 Feb; 104(3):211-27. PubMed ID: 22266473 [TBL] [Abstract][Full Text] [Related]
5. Adjuvant chemotherapy for stage II right-sided and left-sided colon cancer: analysis of SEER-medicare data. Weiss JM; Schumacher J; Allen GO; Neuman H; Lange EO; Loconte NK; Greenberg CC; Smith MA Ann Surg Oncol; 2014 Jun; 21(6):1781-91. PubMed ID: 24643898 [TBL] [Abstract][Full Text] [Related]
6. Adjuvant chemotherapy use and outcomes of patients with high-risk versus low-risk stage II colon cancer. Kumar A; Kennecke HF; Renouf DJ; Lim HJ; Gill S; Woods R; Speers C; Cheung WY Cancer; 2015 Feb; 121(4):527-34. PubMed ID: 25332117 [TBL] [Abstract][Full Text] [Related]
7. Effect of delay in adjuvant oxaliplatin-based chemotherapy for stage III colon cancer. Peixoto RD; Kumar A; Speers C; Renouf D; Kennecke HF; Lim HJ; Cheung WY; Melosky B; Gill S Clin Colorectal Cancer; 2015 Mar; 14(1):25-30. PubMed ID: 25465343 [TBL] [Abstract][Full Text] [Related]
8. Does delay of adjuvant chemotherapy impact survival in patients with resected stage II and III colon adenocarcinoma? Bayraktar UD; Chen E; Bayraktar S; Sands LR; Marchetti F; Montero AJ; Rocha-Lima CM Cancer; 2011 Jun; 117(11):2364-70. PubMed ID: 24048783 [TBL] [Abstract][Full Text] [Related]
9. Variation in Delayed Time to Adjuvant Chemotherapy and Disease-Specific Survival in Stage III Colon Cancer Patients. Becerra AZ; Aquina CT; Mohile SG; Tejani MA; Schymura MJ; Boscoe FP; Xu Z; Justiniano CF; Boodry CI; Swanger AA; Noyes K; Monson JR; Fleming FJ Ann Surg Oncol; 2017 Jun; 24(6):1610-1617. PubMed ID: 27738848 [TBL] [Abstract][Full Text] [Related]
10. Delay in Adjuvant Chemotherapy and Survival Advantage in Stage III Colon Cancer. Turner MC; Farrow NE; Rhodin KE; Sun Z; Adam MA; Mantyh CR; Migaly J J Am Coll Surg; 2018 Apr; 226(4):670-678. PubMed ID: 29378259 [TBL] [Abstract][Full Text] [Related]
11. Benefit of Postresection Adjuvant Chemotherapy for Stage III Colon Cancer in Octogenarians: Analysis of the National Cancer Database. Bergquist JR; Thiels CA; Spindler BA; Shubert CR; Hayman AV; Kelley SR; Larson DW; Habermann EB; Pemberton JH; Mathis KL Dis Colon Rectum; 2016 Dec; 59(12):1142-1149. PubMed ID: 27824699 [TBL] [Abstract][Full Text] [Related]
12. Association between receipt and timing of adjuvant chemotherapy and survival for patients with stage III colon cancer in Alberta, Canada. Lima IS; Yasui Y; Scarfe A; Winget M Cancer; 2011 Aug; 117(16):3833-40. PubMed ID: 21319156 [TBL] [Abstract][Full Text] [Related]
13. Adjuvant chemotherapy for stage II colon cancer with poor prognostic features. O'Connor ES; Greenblatt DY; LoConte NK; Gangnon RE; Liou JI; Heise CP; Smith MA J Clin Oncol; 2011 Sep; 29(25):3381-8. PubMed ID: 21788561 [TBL] [Abstract][Full Text] [Related]
14. Adjuvant chemotherapy is not associated with improved survival for all high-risk factors in stage II colon cancer. Verhoeff SR; van Erning FN; Lemmens VE; de Wilt JH; Pruijt JF Int J Cancer; 2016 Jul; 139(1):187-93. PubMed ID: 26914273 [TBL] [Abstract][Full Text] [Related]
15. Effect of adjuvant chemotherapy on survival benefit in stage III colon cancer patients stratified by age: a Japanese real-world cohort study. Kawamura H; Morishima T; Sato A; Honda M; Miyashiro I BMC Cancer; 2020 Jan; 20(1):19. PubMed ID: 31906959 [TBL] [Abstract][Full Text] [Related]
16. Determining the Optimal Timing for Initiation of Adjuvant Chemotherapy After Resection for Stage II and III Colon Cancer. Sun Z; Adam MA; Kim J; Nussbaum DP; Benrashid E; Mantyh CR; Migaly J Dis Colon Rectum; 2016 Feb; 59(2):87-93. PubMed ID: 26734965 [TBL] [Abstract][Full Text] [Related]
17. Effect of Adjuvant FOLFOX Chemotherapy Duration on Outcomes of Patients With Stage III Colon Cancer. Kumar A; Peixoto RD; Kennecke HF; Renouf DJ; Lim HJ; Gill S; Speers CH; Cheung WY Clin Colorectal Cancer; 2015 Dec; 14(4):262-8.e1. PubMed ID: 26123496 [TBL] [Abstract][Full Text] [Related]
18. Adjuvant chemotherapy is associated with improved survival in patients with stage II colon cancer. Casadaban L; Rauscher G; Aklilu M; Villenes D; Freels S; Maker AV Cancer; 2016 Nov; 122(21):3277-3287. PubMed ID: 27417445 [TBL] [Abstract][Full Text] [Related]
19. Effect of adjuvant chemotherapy on survival of patients with stage III colon cancer diagnosed after age 75 years. Sanoff HK; Carpenter WR; Stürmer T; Goldberg RM; Martin CF; Fine JP; McCleary NJ; Meyerhardt JA; Niland J; Kahn KL; Schymura MJ; Schrag D J Clin Oncol; 2012 Jul; 30(21):2624-34. PubMed ID: 22665536 [TBL] [Abstract][Full Text] [Related]
20. The impact of stage, grade, and mucinous histology on the efficacy of systemic chemotherapy in adenocarcinomas of the appendix: Analysis of the National Cancer Data Base. Asare EA; Compton CC; Hanna NN; Kosinski LA; Washington MK; Kakar S; Weiser MR; Overman MJ Cancer; 2016 Jan; 122(2):213-21. PubMed ID: 26506400 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]